... Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a ... Presentation of Phase 1 dose escalation trial data (at the San Antonio ...
News
- Arvinas Reports Second Quarter 2021 Financial Results and Provides Corporate Update
- Moderna: Q2 Earnings Snapshot
The biotechnology company posted revenue of $4.35 billion in the period, also exceeding Street forecasts. Six analysts surveyed by Zacks expected ...
- Salarius: Q2 Earnings Snapshot
The biotech drug developer posted revenue of $571,400 in the period. Its adjusted revenue was $571,000. The company's shares closed at 80 cents.
- Calithera: Q2 Earnings Snapshot
SOUTH SAN FRANCISCO, Calif. (AP) _ Calithera Biosciences Inc. (CALA) on Thursday reported a loss of $14.3 million in its second quarter.
- NGM Biopharmaceuticals: Q2 Earnings Snapshot
The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 39 cents per share. The biotechnology company posted ...